NCT06358066

Brief Summary

Evaluate clinically the remineralizing potential of self-assembling peptide ( P11-4) fluoride plus in early enamel carious lesions of permanent anterior teeth.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Jun 2024

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

June 6, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 6, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2025

Completed
Last Updated

May 23, 2024

Status Verified

May 1, 2024

Enrollment Period

5 months

First QC Date

March 29, 2024

Last Update Submit

May 21, 2024

Conditions

Keywords

Remineralization

Outcome Measures

Primary Outcomes (1)

  • Remineralization potential

    T0:baseline assessment --\> T1:1 month(Application of Curodont repair flouride plus /fluoride varnish andAssessment of white spot lesion regression)--\> T2: 3 months Assessment of white spot lesion regression\_\_\>T3: 6 months assessment of white spot lesion regression by: Inspection under magnification ICDAS II Score 0:Sound tooth surface: 1. First visual change in enamel. 2. Distinct visual change in enamel visible when wet, lesion must be visible when dry. by:Diagnodent

    1 month

Secondary Outcomes (1)

  • Remineralization potential

    3 months

Study Arms (2)

curodont repair fluoride plus

EXPERIMENTAL

Group I (study group): Teeth will be treated with self-assembling peptide (P11-4) fluoride plus varnish.

Drug: self assembling peptide p11-4 with fluoride

fluoride varnish

ACTIVE COMPARATOR

Group II (control group): Teeth will be treated with fluoride varnish.

Drug: 5% sodium fluoride varnish

Interventions

Self-assembling peptide (P11-4) fluoride plus will be applied according to the manufacturer's instructions by pushing the two cylinders together and will left for 5 min till the tooth surface appears dry to insure its diffusion The remineralizing process of the early enamel carious lesions will be assessed quantitatively using the laser fluorescence DIAGNOdent measuring and assessed qualitatively using ICDAS II scoring system at baseline 1, 3, 6 months post-treatment

Also known as: curodont repair fluoride plus varnish
curodont repair fluoride plus

Fluoride varnish will be applied under manufacturer instructions by applying thin layer of varnish with a brush in strokes The remineralizing process of the early enamel carious lesions will be assessed quantitatively using the laser fluorescence DIAGNOdent measuring and assessed qualitatively using ICDAS II scoring system at baseline 1, 3, 6 months post-treatment

Also known as: charm fluoride varnish
fluoride varnish

Eligibility Criteria

Age10 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Presence of active non-cavitated carious white spot lesions with DIAGNO/dent reading from 5 to 17 ,on labial surfaces of permanent anterior teeth and International Caries Detection And Assessment System II (ICDAS II) ranging between 1 and 3.
  • The children' age range between 10 to14 years old.
  • Children had completed fixed orthodontic treatment within the past week.
  • Good oral hygiene with a plaque index score 0 or 1.
  • No systemic diseases or medication affecting salivary flow.

You may not qualify if:

  • Children with tetracycline pigmentation, dental fluorosis, or enamel hypoplasia.
  • Children had fluoride application less than 3 months before the study.
  • Presence of restoration and cavitation on the surface to be treated.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of Dentistry,Tanta university

Tanta, 31511, Egypt

Location

MeSH Terms

Interventions

FluoridesPaint

Intervention Hierarchy (Ancestors)

AnionsIonsElectrolytesInorganic ChemicalsHydrofluoric AcidFluorine CompoundsManufactured MaterialsTechnology, Industry, and Agriculture

Central Study Contacts

Sara Elgebaly, master

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

March 29, 2024

First Posted

April 10, 2024

Study Start

June 6, 2024

Primary Completion

November 6, 2024

Study Completion

January 6, 2025

Last Updated

May 23, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL
Time Frame
6 months

Locations